 |
T-knife Therapeutics
Last updated: January 20, 2024
Founders: Thomas Blankenstein, Elisa Kieback
Country: Germany | Funding: $197.4M (+)
Website: https://t-knife.com/
T-knife is a developer of T cell receptors intended for T cell therapy of cancer.
Website: https://t-knife.com/
T-knife is a developer of T cell receptors intended for T cell therapy of cancer.
